These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15308664)

  • 21. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A; Thraves PJ; Dritschilo A; Notario V
    Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skeletal muscle deformity and neuronal disorder in Trio exchange factor-deficient mouse embryos.
    O'Brien SP; Seipel K; Medley QG; Bronson R; Segal R; Streuli M
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12074-8. PubMed ID: 11050238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Trio, a Rho Guanine Nucleotide Exchange Factor, in Glomerular Podocytes.
    Maier M; Baldwin C; Aoudjit L; Takano T
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retroviral transduction and oncogenic selection of a cDNA encoding Dbs, a homolog of the Dbl guanine nucleotide exchange factor.
    Whitehead I; Kirk H; Kay R
    Oncogene; 1995 Feb; 10(4):713-21. PubMed ID: 7862449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chondrocyte-derived ezrin-like domain containing protein (CDEP), a rho guanine nucleotide exchange factor, is inducible in chondrocytes by parathyroid hormone and cyclic AMP and has transforming activity in NIH3T3 cells.
    Koyano Y; Kawamoto T; Kikuchi A; Shen M; Kuruta Y; Tsutsumi S; Fujimoto K; Noshiro M; Fujii K; Kato Y
    Osteoarthritis Cartilage; 2001; 9 Suppl A():S64-8. PubMed ID: 11680691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ostip2, a novel oncoprotein that associates with the Rho exchange factor Ost.
    Yamanaka R; Blumenthal R; Lorenzi MV; Tatsumoto T; Miki T
    DNA Cell Biol; 2001 Jul; 20(7):383-90. PubMed ID: 11506702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The guanine nucleotide exchange factor trio mediates axonal development in the Drosophila embryo.
    Bateman J; Shu H; Van Vactor D
    Neuron; 2000 Apr; 26(1):93-106. PubMed ID: 10798395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Rac1- and RhoG-specific GEF domain of Trio targets filamin to remodel cytoskeletal actin.
    Bellanger JM; Astier C; Sardet C; Ohta Y; Stossel TP; Debant A
    Nat Cell Biol; 2000 Dec; 2(12):888-92. PubMed ID: 11146652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tgat oncoprotein functions as a inhibitor of RECK by association of the unique C-terminal region.
    Mori T; Moriuchi R; Okazaki E; Yamada K; Katamine S
    Biochem Biophys Res Commun; 2007 Apr; 355(4):937-43. PubMed ID: 17328864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. M-cadherin activates Rac1 GTPase through the Rho-GEF trio during myoblast fusion.
    Charrasse S; Comunale F; Fortier M; Portales-Casamar E; Debant A; Gauthier-Rouvière C
    Mol Biol Cell; 2007 May; 18(5):1734-43. PubMed ID: 17332503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression cDNA cloning of a serine kinase transforming gene.
    Chan AM; Chedid M; McGovern ES; Popescu NC; Miki T; Aaronson SA
    Oncogene; 1993 May; 8(5):1329-33. PubMed ID: 8479752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic potential of mouse translation elongation factor-1 delta, a novel cadmium-responsive proto-oncogene.
    Joseph P; Lei YX; Whong WZ; Ong TM
    J Biol Chem; 2002 Feb; 277(8):6131-6. PubMed ID: 11711542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
    Velasco JA; Avila MA; Notario V
    Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assignment of TRIO, the Trio gene (PTPRF interacting) to human chromosome bands 5p 15.1-->p 14 by in situ hybridization.
    Taviaux S; Diriong S; Bellanger JM; Streuli M; Debant A
    Cytogenet Cell Genet; 1997; 76(1-2):107-8. PubMed ID: 9154137
    [No Abstract]   [Full Text] [Related]  

  • 35. Activation of gef-h1, a guanine nucleotide exchange factor for RhoA, by DNA transfection.
    Brecht M; Steenvoorden AC; Collard JG; Luf S; Erz D; Bartram CR; Janssen JW
    Int J Cancer; 2005 Feb; 113(4):533-40. PubMed ID: 15455375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the first Rho-GEF inhibitor, TRIPalpha, which targets the RhoA-specific GEF domain of Trio.
    Schmidt S; Diriong S; Méry J; Fabbrizio E; Debant A
    FEBS Lett; 2002 Jul; 523(1-3):35-42. PubMed ID: 12123800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation, characterization, and mapping of the mouse Fgd3 gene, a new Faciogenital Dysplasia (FGD1; Aarskog Syndrome) gene homologue.
    Pasteris NG; Nagata K; Hall A; Gorski JL
    Gene; 2000 Jan; 242(1-2):237-47. PubMed ID: 10721717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NMR structure and mutagenesis of the N-terminal Dbl homology domain of the nucleotide exchange factor Trio.
    Liu X; Wang H; Eberstadt M; Schnuchel A; Olejniczak ET; Meadows RP; Schkeryantz JM; Janowick DA; Harlan JE; Harris EA; Staunton DE; Fesik SW
    Cell; 1998 Oct; 95(2):269-77. PubMed ID: 9790533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoinhibition mechanism of proto-Dbl.
    Bi F; Debreceni B; Zhu K; Salani B; Eva A; Zheng Y
    Mol Cell Biol; 2001 Mar; 21(5):1463-74. PubMed ID: 11238883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies.
    Kurokawa M; Tanaka T; Tanaka K; Ogawa S; Mitani K; Yazaki Y; Hirai H
    Oncogene; 1996 Feb; 12(4):883-92. PubMed ID: 8632911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.